HER2-low Breast Cancer
Also known as: HER2-low Expressing Breast Cancer / Breast Cancer With Low Expression of HER2 / HER2-low-expressing Breast Cancer / HER2 Low Breast Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17573 | Evorpacept | 1 | Recruiting | 1 |
| DB01229 | Paclitaxel | 1 | Withdrawn | 1 |
| DB14962 | Trastuzumab deruxtecan | 1 | Recruiting | 1 |
| DB16342 | Trastuzumab duocarmazine | 1 | Withdrawn | 1 |
| DB11652 | Tucatinib | 1 | Recruiting | 1 |
| DB18230 | XMT-2056 | 1 | Recruiting | 1 |
| DB15471 | Zanidatamab | 1 | Recruiting | 1 |
| DB18290 | Anvatabart opadotin | 2 | Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Active Not Recruiting | 1 |
| DB01248 | Docetaxel | 2 | Active Not Recruiting | 1 |
| DB00445 | Epirubicin | 2 | Active Not Recruiting | 1 |
| DB14993 | Pyrotinib | 2 | Active Not Recruiting | 1 |
| DB14962 | Trastuzumab deruxtecan | Not Available | Recruiting | 2 |